296 related articles for article (PubMed ID: 35135476)
1. Mapping the m1A, m5C, m6A and m7G methylation atlas in zebrafish brain under hypoxic conditions by MeRIP-seq.
Li W; Li X; Ma X; Xiao W; Zhang J
BMC Genomics; 2022 Feb; 23(1):105. PubMed ID: 35135476
[TBL] [Abstract][Full Text] [Related]
2. An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma.
Shao D; Li Y; Wu J; Zhang B; Xie S; Zheng X; Jiang Z
Front Genet; 2022; 13():903117. PubMed ID: 35692827
[No Abstract] [Full Text] [Related]
3. Characterization of the m6A/m1A/m5C/m7G-related regulators on the prognosis and immune microenvironment of glioma by integrated analysis of scRNA-seq and bulk RNA-seq data.
Yang L; Huang Z; Deng Y; Zhang X; Lv Z; Huang H; Sun Q; Liu H; Liang H; He B; Hu F
J Gene Med; 2024 Feb; 26(2):e3666. PubMed ID: 38391150
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a new molecular subtyping and prognostic signature with m6A/m5C/m1A/m7G regulatory genes for hepatocellular carcinoma.
Liu T; Wang Y; Li Z; Sun L; Yang K; Chen J; Han X; Qi L; Zhou X; Wang P
Heliyon; 2023 Nov; 9(11):e21285. PubMed ID: 38027812
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the Divergent Gene Expression Landscapes of m6A/m5C/m1A Methylation Regulators in Hepatocellular Carcinoma Through Single-Cell and Bulk RNA Transcriptomic Analysis.
Liu HT; Rau CS; Liu YW; Hsieh TM; Huang CY; Chien PC; Lin HP; Wu CJ; Chuang PC; Hsieh CH
J Hepatocell Carcinoma; 2023; 10():2383-2395. PubMed ID: 38164510
[TBL] [Abstract][Full Text] [Related]
6. Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer.
Ren M; Fan B; Cao G; Zong R; Feng L; Sun H
BMC Genomics; 2023 Dec; 24(1):776. PubMed ID: 38097948
[TBL] [Abstract][Full Text] [Related]
7. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.
Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D
Front Immunol; 2022; 13():918140. PubMed ID: 35833147
[TBL] [Abstract][Full Text] [Related]
8. A novel m6A/m5C/m1A score signature to evaluate prognosis and its immunotherapy value in colon cancer patients.
Liu J; Dou M; Liu X; Lu Y; Lu W
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11995-12012. PubMed ID: 37421455
[TBL] [Abstract][Full Text] [Related]
9. RNA Methylations in Cardiovascular Diseases, Molecular Structure, Biological Functions and Regulatory Roles in Cardiovascular Diseases.
Zhou W; Wang C; Chang J; Huang Y; Xue Q; Miao C; Wu P
Front Pharmacol; 2021; 12():722728. PubMed ID: 34489709
[TBL] [Abstract][Full Text] [Related]
10. Identification of molecular subtypes and a prognostic signature based on m6A/m5C/m1A-related genes in lung adenocarcinoma.
Zhang Y; Jia Q; Li F; Luo X; Wang Z; Wang X; Wang Y; Zhang Y; Li M; Bian L
Sci Rep; 2024 Mar; 14(1):7543. PubMed ID: 38555384
[TBL] [Abstract][Full Text] [Related]
11. Emerging roles of RNA methylation in gastrointestinal cancers.
Xie S; Chen W; Chen K; Chang Y; Yang F; Lin A; Shu Q; Zhou T; Yan X
Cancer Cell Int; 2020 Dec; 20(1):585. PubMed ID: 33372610
[TBL] [Abstract][Full Text] [Related]
12. Distinct 5-methylcytosine profiles in poly(A) RNA from mouse embryonic stem cells and brain.
Amort T; Rieder D; Wille A; Khokhlova-Cubberley D; Riml C; Trixl L; Jia XY; Micura R; Lusser A
Genome Biol; 2017 Jan; 18(1):1. PubMed ID: 28077169
[TBL] [Abstract][Full Text] [Related]
13. Insights into the regulatory role of RNA methylation modifications in glioma.
Long S; Yan Y; Xu H; Wang L; Jiang J; Xu Z; Liu R; Zhou Q; Huang X; Chen J; Li Z; Wei W; Li X
J Transl Med; 2023 Nov; 21(1):810. PubMed ID: 37964279
[TBL] [Abstract][Full Text] [Related]
14. The role of RNA modification in hepatocellular carcinoma.
Feng Q; Wang D; Xue T; Lin C; Gao Y; Sun L; Jin Y; Liu D
Front Pharmacol; 2022; 13():984453. PubMed ID: 36120301
[TBL] [Abstract][Full Text] [Related]
15. Decomposition of RNA methylome reveals co-methylation patterns induced by latent enzymatic regulators of the epitranscriptome.
Liu L; Zhang SW; Zhang YC; Liu H; Zhang L; Chen R; Huang Y; Meng J
Mol Biosyst; 2015 Jan; 11(1):262-74. PubMed ID: 25370990
[TBL] [Abstract][Full Text] [Related]
16. Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine.
Xu Y; Zhang M; Zhang Q; Yu X; Sun Z; He Y; Guo W
Front Cell Dev Biol; 2021; 9():767668. PubMed ID: 34917614
[TBL] [Abstract][Full Text] [Related]
17. The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases.
Zhou W; Wang X; Chang J; Cheng C; Miao C
Crit Rev Clin Lab Sci; 2022 May; 59(3):203-218. PubMed ID: 34775884
[TBL] [Abstract][Full Text] [Related]
18. PCB126 Exposure Revealed Alterations in m6A RNA Modifications in Transcripts Associated With AHR Activation.
Aluru N; Karchner SI
Toxicol Sci; 2021 Jan; 179(1):84-94. PubMed ID: 33064826
[TBL] [Abstract][Full Text] [Related]
19. RMDisease: a database of genetic variants that affect RNA modifications, with implications for epitranscriptome pathogenesis.
Chen K; Song B; Tang Y; Wei Z; Xu Q; Su J; de Magalhães JP; Rigden DJ; Meng J
Nucleic Acids Res; 2021 Jan; 49(D1):D1396-D1404. PubMed ID: 33010174
[TBL] [Abstract][Full Text] [Related]
20. The epitranscriptome: RNA modifications in vascular remodelling.
Nossent AY
Atherosclerosis; 2023 Jun; 374():24-33. PubMed ID: 36400603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
